Cargando…

Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods

Escherichia coli is a leading cause of community-acquired and health care-associated bloodstream infections (BSIs) worldwide. Limited information is available regarding the changes in population dynamics of human E. coli over extended time periods, especially among nonbiased E. coli isolates in larg...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pitout, Johann D. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694108/ https://www.ncbi.nlm.nih.gov/pubmed/34935445 http://dx.doi.org/10.1128/msphere.00956-21

Ejemplares similares

Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance
por: Pitout, Johann D. D.
Publicado: (2012)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections
por: Shropshire, William C., et al.
Publicado: (2023)

Economic Burden of Patients with Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli
por: Wang, Yuan, et al.
Publicado: (2020)

Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Patients with Liver Cirrhosis
por: Chen, Wen-Chi, et al.
Publicado: (2021)

Trends in Population Dynamics of Escherichia coli Sequence Type 131, Calgary, Alberta, Canada, 2006–2016
por: Peirano, Gisele, et al.
Publicado: (2020)

The Significance of Epidemic Plasmids in the Success of Multidrug-Resistant Drug Pandemic Extraintestinal Pathogenic Escherichia coli
por: Pitout, Johann D. D., et al.
Publicado: (2023)

Escherichia coli ST131: a multidrug-resistant clone primed for global domination
por: Pitout, Johann D.D., et al.
Publicado: (2017)

Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary
por: Pitout, Johann D.D., et al.
Publicado: (2007)

The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023)

Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period
por: Royer, Guilhem, et al.
Publicado: (2021)

Complete Genome Sequence of Escherichia coli J53, an Azide-Resistant Laboratory Strain Used for Conjugation Experiments
por: Matsumura, Yasufumi, et al.
Publicado: (2018)

Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
por: Coque, Teresa M., et al.
Publicado: (2008)

The bacterial genetic determinants of Escherichia coli capacity to cause bloodstream infections in humans
por: Burgaya, Judit, et al.
Publicado: (2023)

Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species
por: Kim, Moonsuk, et al.
Publicado: (2019)

Faecal carriage of ESBL producing and colistin resistant Escherichia coli in avian species over a 2-year period (2017-2019) in Zimbabwe
por: Takawira, Faustinos Tatenda, et al.
Publicado: (2022)

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
por: Chaubey, Vikas P, et al.
Publicado: (2010)

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection
por: Leistner, Rasmus, et al.
Publicado: (2014)

Trend in Antibiotic Resistance of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae Bloodstream Infections
por: Bayraktar, Banu, et al.
Publicado: (2019)

Global Incidence of Carbapenemase-Producing Escherichia coli ST131
por: Peirano, Gisele, et al.
Publicado: (2014)

Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015–2017
por: Peirano, Gisele, et al.
Publicado: (2022)

Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible
por: Baker, Thomas M, et al.
Publicado: (2018)

Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study
por: MacKinnon, Melissa C., et al.
Publicado: (2021)

Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing
por: Paramita, Rafika Indah, et al.
Publicado: (2020)

Clinical and Molecular Epidemiology of Community-Onset Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli over a 6-Year Period
por: Kang, Cheol-In, et al.
Publicado: (2013)

Mortality risk of bloodstream infection caused by either Escherichia coli or Klebsiella pneumoniae producing extended-spectrum β-lactamase: a prospective cohort study
por: Sianipar, Osman, et al.
Publicado: (2019)

Synthetic addiction extends the productive life time of engineered Escherichia coli populations
por: Rugbjerg, Peter, et al.
Publicado: (2018)

Isolation of extended‐spectrum β‐lactamase‐producing Escherichia coli from Japanese red fox (Vulpes vulpes japonica)
por: Asai, Tetsuo, et al.
Publicado: (2022)

Escherichia coli bloodstream infection preceding the diagnosis of rectal carcinoma
por: Thoma, Reto, et al.
Publicado: (2018)

Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2012)

478. Outcomes of Extended-Spectrum β-Lactamase-Producing Escherichia coli Bloodstream Infection in Neutropenic Patients with Hematological Malignancies
por: Aslam, Sadaf, et al.
Publicado: (2019)

Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Pitout, Johann DD
Publicado: (2009)

Homologous Escherichia coli Identified in Cerebrospinal Fluid and Bloodstream
por: Shi, Qingmiao, et al.
Publicado: (2021)

210. Evaluating the Costs of Escherichia coli Bloodstream Infections: A Population-Based Cohort Study
por: King, Teagan, et al.
Publicado: (2023)

Antimicrobial Resistance and Molecular Epidemiology of Escherichia coli Causing Bloodstream Infections in Three Hospitals in Shanghai, China
por: Wang, Su, et al.
Publicado: (2016)

Antibiotic Resistance Profile and Diversity of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam
por: Hung, Pham Ngoc, et al.
Publicado: (2019)

Commentary: Synthetic Addiction Extends the Productive Life Time of Engineered Escherichia coli Populations
por: Enrico Bena, Chiara, et al.
Publicado: (2018)

Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections
por: Kim, Yong Chan, et al.
Publicado: (2023)

Extended spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Indonesia and South East Asian countries: GLASS Data 2018
por: Sunarno, Sunarno, et al.
Publicado: (2023)

Effect of temperature on Escherichia coli bloodstream infection in a nationwide population-based study of incidence and resistance
por: Feldman, Sarah F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1nmkr4bbc4pj6gvjqlhqhk39fv